News

The Latvian Medicines Verification Organization (LZVO) has signed a contract with the company Design Data for the use of the Serial BI data analytics solution (a tool based on Microsoft Power BI).

The Latvian Medicines Verification Organisation (LZVO) has updated the information in the webpage section “Questions and answers”.

Intermarket transactions (IMTs) are a core part of the EMVS but present their own unique challenges.

The Latvian Medicines Verification Organization (LZVO) is launching The Newsletter No. 6, where you can find the most important information about events in the world of medicines verification in the second quarter of 2023.

There have been team changes in the Latvian Medicines Verification Organization (LZVO). Since July 17, 2023, Sanda Čerdinceva has taken on the role of the new Quality Manager.

In the 2nd quarter of 2023, 27 million transactions have been performed in the Latvian Medicines Verification System (LZVS), of which 7 million packages were decommissioned and supplied to patients.